Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Motexafin Gadolinium and Docetaxel for Second Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

NCT00373204 is registered in ClinicalTrials.gov with Pharmacyclics LLC. as lead sponsor.

NCT NCT00373204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00373204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Motexafin Gadolinium and Docetaxel for Second Line Treatment of Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
Pharmacyclics LLC.
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2006
Completion date
May 31, 2008
Enrollment
50 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer